PortView
First Trust NYSE Arca Biotechnology Index Fund (FBT) ETF Holdings & Analysis
ETFOther
What FBT does
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| Halozyme Therapeutics, Inc. | 4.38% | |
| Regeneron Pharmaceuticals, Inc. | 3.84% | |
| NeoGenomics, Inc. | 3.83% | |
| Corcept Therapeutics Inc. | 3.82% | |
| Amgen Inc. | 3.73% | |
| BeOne Medicines Ltd. (ADR) | 3.72% | |
| Natera, Inc. | 3.68% | |
| Repligen Corporation | 3.65% | |
| argenx SE (ADR) | 3.63% | |
| Gilead Sciences, Inc. | 3.58% |
Sector allocation
| Healthcare | 100.00% |
Geographic allocation
| United States | 82.35% |
| Switzerland | 3.78% |
| Germany | 3.69% |
| Netherlands | 3.66% |
| Denmark | 3.56% |
| Ireland | 2.85% |
| Other | 0.11% |
PortView Portfolio Insights
PortView analyzes how FBT fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze FBT in PortView →Related securities
Related stocks
Frequently asked questions
- What does FBT track?
- FBT is the First Trust NYSE Arca Biotechnology Index Fund, a Other ETF.
- What is the expense ratio of FBT?
- Expense ratio data for FBT is shown on the page when available from our data provider.
- What are the largest holdings in FBT?
- Top holdings include HALO, REGN, NEO, CORT, AMGN.
- How can PortView analyze FBT overlap with other ETFs?
- PortView computes the holdings overlap between FBT and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.